Stocks and Investing
Stocks and Investing
Tue, April 28, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, April 27, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $45 on, Apr 27th, 2020
Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $48 to $45 on, Apr 27th, 2020.
Matthew has made no other calls on AVNS in the last 4 months.
There are 4 other peers that have a rating on AVNS. Out of the 4 peers that are also analyzing AVNS, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kristen Stewart of "Barclays" Upgraded from Sell to Hold on, Monday, April 13th, 2020
- Rick Wise of "Stifel" Maintained at Hold with Decreased Target to $32 on, Wednesday, April 1st, 2020
These are the ratings of the 2 analyists that currently disagree with Matthew
- David Lewis of "Morgan Stanley" Maintained at Sell with Decreased Target to $29 on, Friday, March 27th, 2020
- Chris Cooley of "Stephens & Co." Maintained at Buy with Decreased Target to $30 on, Monday, March 23rd, 2020